Correlation Between Plandai Biotech and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Plandai Biotech and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Plandai Biotech and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and Pmv Pharmaceuticals.

Diversification Opportunities for Plandai Biotech and Pmv Pharmaceuticals

-0.3

Correlation Coefficient

Plandai Biotech  Pmv Pharmaceuticals

Very good diversification

The 3 months correlation between Plandai and Pmv is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Plandai Biotech and Pmv Pharmaceuticals

Given the investment horizon of 90 days Plandai Biotech is expected to generate 7.32 times more return on investment than Pmv Pharmaceuticals. However, Plandai Biotech is 7.32 times more volatile than Pmv Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  0.04  in Plandai Biotech on September 4, 2024 and sell it today you would lose (0.03) from holding Plandai Biotech or give up 75.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Plandai Biotech  vs.  Pmv Pharmaceuticals

Plandai Biotech

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pmv Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Plandai Biotech and Pmv Pharmaceuticals

The main advantage of trading using opposite Plandai Biotech and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind Plandai Biotech and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.